Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Smith & Nephew Plc    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
12/05/2019 12/06/2019 12/09/2019 12/10/2019 12/11/2019 Date
1672(c) 1676.5(c) 1675.5(c) 1684.5(c) 1686 Last
1 477 921 1 564 017 1 101 277 1 697 446 458 920 Volume
+0.66% +0.27% -0.06% +0.54% +0.09% Change
More quotes
Financials (USD)
Sales 2019 5 115 M
EBIT 2019 1 158 M
Net income 2019 627 M
Debt 2019 1 731 M
Yield 2019 1,65%
Sales 2020 5 372 M
EBIT 2020 1 234 M
Net income 2020 794 M
Debt 2020 1 312 M
Yield 2020 1,90%
P/E ratio 2019 30,7x
P/E ratio 2020 24,1x
EV / Sales2019 4,11x
EV / Sales2020 3,84x
Capitalization 19 315 M
More Financials
Company
Smith & Nephew specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows: - specialized surgery (74%): orthopedics (primarily orthopedic implants ; hips, knees and shoulders) and endoscopy (surgery and damaged... 
More about the company
Surperformance© ratings of Smith & Nephew Plc
Trading Rating : Investor Rating :
More Ratings
Latest news on SMITH & NEPHEW PLC
12/04SMITH & NEPHEW : +Nephew announces first surgeries using new JOURNEY II Unicompa..
AQ
12/02SMITH & NEPHEW : Additional Listing
PU
11/18SMITH & NEPHEW : +Nephew invests in non-profit fund
AQ
11/11SMITH & NEPHEW : +Nephew launches industry-first OR3O Dual Mobility System utili..
AQ
11/08SMITH & NEPHEW : +Nephew launches industry-first OR3O™ Dual Mobility Syste..
PU
11/05SMITH & NEPHEW : Investor presentation October - December 2019
PU
10/31SMITH & NEPHEW : +Nephew Third Quarter 2019 Trading Report
PU
10/31SMITH & NEPHEW : Trading Statement
PU
10/22EUROPE : European shares rise amid Brexit tussle as focus shifts to earnings
RE
10/21LONDON MARKETS: Pound Dips, FTSE 100 Steady As Boris Johnson's Bid To Hold Ne..
DJ
10/21EUROPE MARKETS: Banks Drive European Markets Higher As Investors Monitor Brex..
DJ
10/21SMITH & NEPHEW : +Nephew CEO steps down over pay, ex-Roche Diagnostics chief to ..
RE
10/21SMITH & NEPHEW : +Nephew CEO to step down, ex-Roche Diagnostics chief to take ov..
RE
10/21SMITH & NEPHEW : +Nephew announces change of Chief Executive Officer
PU
10/21SMITH & NEPHEW : Directorate Change
PU
More news
News in other languages on SMITH & NEPHEW PLC
11/21SMITH & NEPHEW : premier conseil d'achat de Citi
10/03SMITH & NEPHEW : Ex-dividend day for interim dividend
05/09SMITH & NEPHEW : Neue NICE-Richtlinie bestätigt bessere Ergebnisse ohne zusätzli..
05/09ATTENTION - RECTIFICATION : Revoici la dépêche corrigée : La nouvelle directive ..
05/02STOCK MARKET PARIS : Les valeurs à suivre à Paris et en Europe
More news
Analyst Recommendations on SMITH & NEPHEW PLC
More recommendations
Sector news : Medical Devices & Implants
12/02Sanofi agrees to sell Seprafilm to Baxter for $350 million
RE
12/02The EU is not finished yet with Google
12/02BAXTER INTERNATIONAL : to Acquire Seprafilm Adhesion Barrier from Sanofi
DJ
11/30AMAZON.COM, TIFFANY, WALT DISNEY : Stocks That Defined the Week -- WSJ
DJ
11/27Facebook gets Beat Games, US pharma in court, Dell disappoints…
More sector news : Medical Devices & Implants
Chart SMITH & NEPHEW PLC
Duration : Period :
Smith & Nephew Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SMITH & NEPHEW PLC
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 24,03  $
Last Close Price 22,12  $
Spread / Highest target 28,0%
Spread / Average Target 8,66%
Spread / Lowest Target -13,5%
EPS Revisions
Managers
NameTitle
Roland D. Diggelmann Chief Executive Officer & Non-Executive Director
Roberto Quarta Chairman
Mark Gladwell President-Global Operations
Graham James Baker Chief Financial Officer & Director
Vasant Padmanabhan President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SMITH & NEPHEW PLC15.06%19 385
STRYKER CORPORATION26.40%74 180
WRIGHT MEDICAL GROUP N.V.8.45%3 732
GLAUKOS CORPORATION5.48%2 567
INSPIRE MEDICAL SYSTEMS, INC.72.47%1 705
JAPAN LIFELINE CO., LTD.15.33%1 149